NCT00197002 - Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age | Biotech Hunter

Enrollment

521

Participants

Timeline

Start Date

September 11, 2003

Primary Completion Date

January 16, 2006

Study Completion Date

January 16, 2006

Conditions

Hepatitis A

Interventions

BIOLOGICAL

GSK Biologicals 2-dose inactivated hepatitis A vaccine (Havrix)

Two doses, administered intramuscularly in the right anterolateral thigh.

BIOLOGICAL

Prevnar™

One dose, administered intramuscularly in the left anterolateral thigh.

Trial Locations (18)

11794

GSK Investigational Site, Stony Brook

15241

GSK Investigational Site, Pittsburgh

27514

GSK Investigational Site, Chapel Hill

40004

GSK Investigational Site, Bardstown

40202

GSK Investigational Site, Louisville

44118

GSK Investigational Site, University Heights

49008

GSK Investigational Site, Kalamazoo

68131

GSK Investigational Site, Omaha

75235

GSK Investigational Site, Dallas

80112

GSK Investigational Site, Centennial

84109

GSK Investigational Site, Salt Lake City

84121

GSK Investigational Site, Salt Lake City

89014

GSK Investigational Site, Las Vegas

89025

GSK Investigational Site, North Las Vegas

98664

GSK Investigational Site, Vancouver

02115

GSK Investigational Site, Boston

02118

GSK Investigational Site, Boston

78205-2489

GSK Investigational Site, San Antonio